[go: up one dir, main page]

DK0614456T3 - 1alfa,24(S)-dihydroxy-vitamin D2, dets fremstilling og anvendelse - Google Patents

1alfa,24(S)-dihydroxy-vitamin D2, dets fremstilling og anvendelse

Info

Publication number
DK0614456T3
DK0614456T3 DK93921243T DK93921243T DK0614456T3 DK 0614456 T3 DK0614456 T3 DK 0614456T3 DK 93921243 T DK93921243 T DK 93921243T DK 93921243 T DK93921243 T DK 93921243T DK 0614456 T3 DK0614456 T3 DK 0614456T3
Authority
DK
Denmark
Prior art keywords
dihydroxy vitamin
alpha
converted
preparation
1alpha
Prior art date
Application number
DK93921243T
Other languages
English (en)
Inventor
Ronald L Horst
Glenville Jones
Nicholas J Koszewski
Timothy A Reinhardt
Raju Penmasta
Stephen Strugnell
Liang Guo
Sanjay K Singhal
Lei Zhao
Charles W Bishop
Joyce C Knutson
Robert M Moriarty
Original Assignee
Bone Care Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Care Int Inc filed Critical Bone Care Int Inc
Application granted granted Critical
Publication of DK0614456T3 publication Critical patent/DK0614456T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
DK93921243T 1992-08-28 1993-08-30 1alfa,24(S)-dihydroxy-vitamin D2, dets fremstilling og anvendelse DK0614456T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94024692A 1992-08-28 1992-08-28
PCT/US1993/008141 WO1994005630A1 (en) 1992-08-28 1993-08-30 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE

Publications (1)

Publication Number Publication Date
DK0614456T3 true DK0614456T3 (da) 1999-12-06

Family

ID=25474483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93921243T DK0614456T3 (da) 1992-08-28 1993-08-30 1alfa,24(S)-dihydroxy-vitamin D2, dets fremstilling og anvendelse

Country Status (11)

Country Link
US (1) US6143910A (da)
EP (1) EP0614456B1 (da)
JP (1) JP3179495B2 (da)
AT (1) ATE181062T1 (da)
AU (2) AU4841193A (da)
CA (1) CA2121689C (da)
DE (1) DE69325253T2 (da)
DK (1) DK0614456T3 (da)
ES (1) ES2134267T3 (da)
GR (1) GR3030939T3 (da)
WO (1) WO1994005630A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
TWI247001B (en) 1996-07-01 2006-01-11 Chugai Pharmaceutical Co Ltd The method for purifying vitamin d derivatives and its crystalline products
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
EP2340840B1 (en) * 1998-03-27 2012-08-29 Oregon Health Sciences University Pulse dose Vitamin D drug for the treatment of hyperproliferative skin diseases
US6362350B1 (en) 1999-07-01 2002-03-26 Wisconsin Alumni Research Foundation Crystalline 1α, 24(S)-dihydroxyvitamin D2 and method of purification thereof
IL153378A0 (en) * 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
DK1331927T3 (da) * 2000-10-27 2008-05-05 Leo Pharma As Topisk komposition der indeholder mindst et D-vitamin eller en D-vitamin analog og mindst et kosttikosteroid
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
WO2009100258A1 (en) * 2008-02-05 2009-08-13 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical solid state forms

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670190A (en) * 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
GB1583749A (en) * 1976-06-03 1981-02-04 Res Inst Medicine Chem Vitamin d derivatives
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4338250A (en) * 1981-04-27 1982-07-06 Wisconsin Alumni Research Foundation 1-Hydroxylation process
US4719205A (en) * 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
US4719204A (en) * 1984-03-05 1988-01-12 Wisconsin Alumni Research Foundation Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
DK0550702T3 (da) 1991-01-08 1999-11-01 Bone Care Int Inc Fremgangsmåde til fremstilling og anvendelse af 1alfa,24-dihydroxy-vitamin D2

Also Published As

Publication number Publication date
DE69325253D1 (de) 1999-07-15
DE69325253T2 (de) 1999-12-02
EP0614456A4 (en) 1995-01-04
CA2121689A1 (en) 1994-03-17
EP0614456B1 (en) 1999-06-09
EP0614456A1 (en) 1994-09-14
US6143910A (en) 2000-11-07
AU4841193A (en) 1994-03-29
JP3179495B2 (ja) 2001-06-25
ATE181062T1 (de) 1999-06-15
AU1486497A (en) 1997-05-22
WO1994005630A1 (en) 1994-03-17
GR3030939T3 (en) 1999-11-30
ES2134267T3 (es) 1999-10-01
CA2121689C (en) 2008-03-18
JPH07500848A (ja) 1995-01-26

Similar Documents

Publication Publication Date Title
ES2134207T3 (es) Procedimiento de preparacion y de utilizacion de la vitamina 1alfa,24-dihidroxi vitamina d2.
DK0614456T3 (da) 1alfa,24(S)-dihydroxy-vitamin D2, dets fremstilling og anvendelse
MX9203050A (es) Compuestos de analogos de triptamina.
ATE172963T1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
AR019823A1 (es) Una composicion cosmetica para el cuidado de la piel y un metodo para reducir la irritacion o el picor de la piel
ES2077199T3 (es) Nuevas piperacinas 1,4-disustituidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
WO1994005630B1 (en) 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ATE177111T1 (de) Doppelbindungs-isomer von equilin erhalten durch säure-isomerisierung
MX9501849A (es) Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos.
ATE193651T1 (de) Therapeutisches system zur behandlung der psoriasis
AU623805B2 (en) New use of anti-progestomimetic compounds
DK0471718T3 (da) Paracetamolholdigt farmaceutisk præparat
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
AU6814387A (en) Phenylacetonitriles which are substituted by basic groups, their preparation and drugs containing these substances
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
MX9305151A (es) Metodo para el tratamiento de enfermedades de la piel.
ES2123796T3 (es) Derivados de acidos fosfono-succinicos y su utilizacion como medicamentos.
EP0261891A3 (en) Pharmaceutical compositions containing etiochiolandione
FR2415622A1 (fr) Amino alcools derives de l'ortho-hydroxy cinnamate de methyle applicables notamment comme medicaments
FI834737A0 (fi) Nya kosmetiska kompositioner innehaollande prenylamin och foerfarande foer framstaellning av dessa